Niki BioSolutions NIKI

Niki BioSolutions appoints new CFO

Form
8-K
Filed
Importance
Major
  1. Thomas Freeburg appointed CFO on Oct 9, 2026
  2. Base salary $250,000 with potential increase to $275,000
  3. 50,000 stock options with $8.83 exercise price
  4. Employment agreement allows 45-day termination notice

Written from the 8-K on EDGAR. Check the filing before you rely on it.

Get an email when Niki BioSolutions files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 3829 and related industry codes: the same peer list as the financial tables.